Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can prayer and talk therapy calm the mind during cancer?

NCT ID NCT07833982

NEW Symptom relief Sponsor: Shaheed Zulfikar Ali Bhutto Institute of Science and Technology (SZABIST) University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 22, 2026 · Last updated Sep 22, 2026

Summary

Researchers are testing whether supportive psychotherapy combined with daily listening to Surah Ar-Rahman recitation reduces depression, anxiety, and stress in cancer patients. Sixty adults with stage I or II cancer who are receiving or have received treatment join the study. Half receive 12 weeks of weekly counseling plus daily audio listening; the other half receive standard care. The team measures distress, hope, and quality of life before and after.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
supportive psychotherapy combined with daily listening to a Quran recitation (Surah Ar-Rahman)
What this could lead to
If it helps, this could offer a low-cost, culturally grounded way to ease distress and lift hope for people living with cancer.
What could go wrong
The trial is small and early, so any benefit may be modest or may not hold up in larger studies. Distress can also improve on its own, making effects hard to pin down.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Inclusion Criteria * Aged 18 years or older * Have a confirmed diagnosis of cancer stage I and II will be included to obtain a relatively comparable clinical population and reduce variability associated with advanced disease and palliative care needs. * Are currently receiving or have received cancer-related treatment, such as chemotherapy, radiotherapy, surgery, immunotherapy, or other oncological treatment. * Education level will be matric atleast * Muslim patients * Able to communicate and provide consent Exclusion Criteria: * • Severe psychiatric disorders * Cognitive impairment * Hearing impairments preventing audio participation * Physically unfit for this study's interventions (for example who are bed-bonded or too weak to engage in the study interventions)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder cancer Depression neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Psychological distress (depression, anxiety and stress) cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Oncology department, IMPS, Noori & Shia International Hospital

    Islamabad, 44000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.